Checklist identification of Candidates for Systemic Therapy in Adult Patients With Atopic Dermatitis in Germany: A Multicenter Study

医学 检查表 指南 全身疗法 德国的 特应性皮炎 生活质量(医疗保健) 重症监护医学 儿科 物理疗法 内科学 皮肤病科 病理 考古 乳腺癌 认知心理学 护理部 癌症 历史 心理学
作者
Annice Heratizadeh,Martin Mempel,Ralph von Kiedrowski,S. Hagl,T. Mosch,B. Fritz,Thomas Werfel
出处
标识
DOI:10.1111/jdv.19465
摘要

The German S2k guideline is the first to include a checklist that captures atopic dermatitis (AD) signs and symptoms as well as the lack of treatment response to identify patients eligible for systemic therapy.Identifying candidates for a start/switch of systemic therapy in adult AD patients in Germany by applying the S2k guideline's checklist.In this German multicentre, cross-sectional, non-interventional study (German Clinical Trials Register number: DRKS00023296), adult patients with mild to severe AD were enrolled at dermatological outpatient clinics and offices between April and October 2021. Demographics, clinical characteristics and quality of life were collected using questionnaires during one single visit. Eligibility for a start/switch of systemic AD therapy was evaluated according to the criteria of the German S2k guideline's checklist.Atopic dermatitis patients (575) were included in the analysis. One hundred and sixty-four patients (28.5%) received systemic (SYS) AD therapy and 411 patients (71.5%) did not (TOP). Of the TOP therapy patients, 38.7% were eligible to start systemic AD therapy, and about half of those (49.1%), were scheduled to start systemic AD therapy. The most frequent reason deciding against a systemic therapy was the patient's wish. Although 29.3% of SYS patients were eligible for a switch according to the criteria of the German S2k guideline's checklist, the majority (81.3%) did not switch AD therapy.This is the first study on the implementation of the German S2k guideline's checklist in everyday care of AD patients in Germany. More than one-third of the TOP patients were identified as eligible for systemic treatment. By applying the guideline's checklist criteria, another one-third of SYS patients may have benefited from a change of current systemic therapy. The use of the German S2k guideline's checklist in routine care represents an important tool to ensure effective patient care and identify inadequately treated patients.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
朱1591发布了新的文献求助10
1秒前
阿靖完成签到,获得积分10
1秒前
2秒前
2秒前
lynn_zhang完成签到,获得积分10
2秒前
2秒前
3秒前
长情咖啡豆完成签到,获得积分10
3秒前
4秒前
顾矜应助皮皮采纳,获得10
4秒前
能干的寒凡完成签到,获得积分10
4秒前
5秒前
Flickayujiao完成签到 ,获得积分10
5秒前
科研通AI6.2应助chen采纳,获得10
5秒前
5秒前
英俊的铭应助cheche采纳,获得10
6秒前
一堃发布了新的文献求助10
6秒前
6秒前
6秒前
开放剑鬼完成签到,获得积分10
6秒前
[刘小婷]完成签到,获得积分10
7秒前
molihuakai应助科研通管家采纳,获得10
7秒前
田様应助科研通管家采纳,获得20
8秒前
Lucas应助科研通管家采纳,获得10
8秒前
8秒前
8秒前
脆蜜金桔应助科研通管家采纳,获得10
8秒前
结实新梅发布了新的文献求助10
8秒前
我是小汪应助科研通管家采纳,获得10
8秒前
8秒前
桐桐应助科研通管家采纳,获得10
8秒前
爆米花应助科研通管家采纳,获得10
8秒前
桐桐应助科研通管家采纳,获得10
8秒前
开心的吐司完成签到,获得积分10
8秒前
bkagyin应助木子小微采纳,获得10
8秒前
8秒前
所所应助科研通管家采纳,获得10
8秒前
9秒前
Ava应助科研通管家采纳,获得10
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Picture this! Including first nations fiction picture books in school library collections 2000
The Cambridge History of China: Volume 4, Sui and T'ang China, 589–906 AD, Part Two 1500
Cowries - A Guide to the Gastropod Family Cypraeidae 1200
Quality by Design - An Indispensable Approach to Accelerate Biopharmaceutical Product Development 800
ON THE THEORY OF BIRATIONAL BLOWING-UP 666
Signals, Systems, and Signal Processing 610
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6391943
求助须知:如何正确求助?哪些是违规求助? 8207293
关于积分的说明 17372727
捐赠科研通 5445397
什么是DOI,文献DOI怎么找? 2879009
邀请新用户注册赠送积分活动 1855426
关于科研通互助平台的介绍 1698576